跳至主要内容
临床试验/JPRN-UMIN000044125
JPRN-UMIN000044125招募中2 期

Study on the safety of modified MCT ketogenic diet and standard therapy combination therapy for breast cancer patients - Study on MCT ketogenic diet for breast cancer patients

Toho University Omori Medical Center, Department of Nutrition Therapy Center0 个研究点目标入组 50 人开始时间: 2021年5月7日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Weight loss of 5% or more has been observed in the last 3 months. 2. Highly advanced example (Exclusion example) When there is liver metastasis, deterioration of liver function, jaundice, and ascites. (Exclusion example) When there is lung metastasis and there are clinical symptoms such as pleural effusion and respiratory distress. However, bone metastases and brain metastases are not excluded. 3. If you have a history of ileus or peritoneal dissemination.

研究者

发起方
Toho University Omori Medical Center, Department of Nutrition Therapy Center

相似试验